1.6500
-0.1500
(-8.33%)
At close: January 10 at 4:00:02 PM EST
1.8400
+0.19
+(11.52%)
After hours: January 10 at 7:52:14 PM EST
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 411.2k | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| HUNT RONALD M Director | -- | Indirect | -- | Aug 6, 2024 |
| FISHMAN COREY N Chief Executive Officer | -- | Direct | -- | Aug 6, 2024 |
| DUNNE MICHAEL W Director | Conversion of Exercise of derivative security at price 1.21 per share. | Direct | 128,559 | Aug 6, 2024 |
| DUNNE MICHAEL W Director | Purchase at price 1.40 per share. | Direct | 35,000 | Dec 22, 2023 |
| DUNNE MICHAEL W Director | Purchase at price 1.84 per share. | Direct | 18,442 | Dec 18, 2023 |
| PUTTAGUNTA SAILAJA Officer | -- | Direct | -- | Dec 1, 2023 |
| DUNNE MICHAEL W Director | Purchase at price 2.03 per share. | Direct | 40,690 | Nov 22, 2023 |
| FISHMAN COREY N Chief Executive Officer | Purchase at price 1.59 per share. | Direct | 15,863 | Nov 20, 2023 |
| HUNT RONALD M Director | -- | Direct | -- | Sep 29, 2023 |
| DUNNE MICHAEL W Director | -- | Direct | -- | Sep 29, 2023 |
| HUNT RONALD M Director | -- | Direct | -- | Jun 30, 2023 |
| DUNNE MICHAEL W Director | -- | Direct | -- | Jun 30, 2023 |
| HECHT BETH P Director | -- | Direct | -- | Jun 15, 2023 |
| DUNNE MICHAEL W Director | -- | Direct | -- | Jun 15, 2023 |
| CHIN MARK Director | -- | Direct | -- | Jun 15, 2023 |
| HUNT RONALD M Director | -- | Direct | -- | Mar 31, 2023 |
| DUNNE MICHAEL W Director | -- | Direct | -- | Mar 31, 2023 |
| DUNNE MICHAEL W Director | -- | Direct | -- | Mar 31, 2023 |
| FISHMAN COREY N Chief Executive Officer | Conversion of Exercise of derivative security at price 0.96 per share. | Direct | 13,760 | Mar 10, 2023 |
| MATTHEWS JUDITH M Chief Financial Officer | Conversion of Exercise of derivative security at price 0.96 per share. | Direct | 6,399 | Mar 10, 2023 |
| FISHMAN COREY N Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 10, 2023 |
| MATTHEWS JUDITH M Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 10, 2023 |
Related Tickers
SPRO Spero Therapeutics, Inc.
0.9800
-2.00%
MIST Milestone Pharmaceuticals Inc.
2.0800
-5.45%
LPCN Lipocine Inc.
4.8900
-6.50%
CNSP CNS Pharmaceuticals, Inc.
0.1178
+1.55%
JAGX Jaguar Health, Inc.
1.0000
-8.26%
CARA Cara Therapeutics, Inc.
4.7500
0.00%
EQ Equillium, Inc.
0.7006
-2.21%
VYNE VYNE Therapeutics Inc.
3.4300
-12.50%
CKPT Checkpoint Therapeutics, Inc.
3.1600
-1.56%
IBIO iBio, Inc.
2.5500
-6.25%